Important safety information: Semaglutide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
But rather, it is a progressive clinical protocol, and how it is structured matters as much as the medication itself
Experts says the drug needs to be used over a lifetime to keep off the pounds 'As all individuals initially being offered semaglutide via the NHS will be supported by specialist weight management services this should including support from a specialist dietitian.' What other weight loss drugs are available on the NHS
Constipation means having fewer bowel movements than usual or difficulty passing stool
Yale Medicine notes that gastrointestinal symptoms such as nausea, vomiting and diarrhea are the most common side effects for GLP-1s in pill and injectable forms
Privacy and Convenience Enjoy the convenience of virtual consultations and home delivery, all while maintaining your privacy